4 results on '"Naumiuk Ł"'
Search Results
2. Mycobacterium chimaera - a new threat for cardiac surgical patients?
- Author
-
Jaworski R, Naumiuk Ł, Paczkowski K, Formella D, Pek R, Zieliński J, and Haponiuk I
- Abstract
An outbreak of invasive Mycobacterium chimaera infections associated with "heater-cooler" devices in patients treated with cardiac surgery has been described worldwide. The authors summarize the current state of knowledge regarding the epidemiology, diagnostics, treatment, and prevention of Mycobacterium chimaera infections in patients after cardiothoracic surgery.
- Published
- 2017
- Full Text
- View/download PDF
3. Mechanisms of azole resistance among clinical isolates of Candida glabrata in Poland.
- Author
-
Szweda P, Gucwa K, Romanowska E, Dzierz Anowska-Fangrat K, Naumiuk Ł, Brillowska-Da Browska A, Wojciechowska-Koszko I, and Milewski S
- Subjects
- Amphotericin B pharmacology, Candida glabrata isolation & purification, Candidiasis microbiology, Cytochrome P-450 Enzyme System genetics, Echinocandins pharmacology, Fungal Proteins genetics, Gene Expression Profiling, Hospitals, Humans, Membrane Transport Proteins genetics, Microbial Sensitivity Tests, Poland, Polymerase Chain Reaction, Sequence Analysis, DNA, Antifungal Agents pharmacology, Azoles pharmacology, Candida glabrata drug effects, Drug Resistance, Fungal
- Abstract
Candida glabrata is currently ranked as the second most frequently isolated aetiological agent of human fungal infections, next only to Candida albicans. In comparison with C. albicans, C. glabrata shows lower susceptibility to azoles, the most common agents used in treatment of fungal infections. Interestingly, the mechanisms of resistance to azole agents in C. albicans have been much better investigated than those in C. glabrata. The aim of the presented study was to determine the mechanisms of resistance to azoles in 81 C. glabrata clinical isolates from three different hospitals in Poland. The investigation was carried out with a Sensititre Yeast One test and revealed that 18 strains were resistant to fluconazole, and 15 were cross-resistant to all other azoles tested (voriconazole, posaconazole and itraconazole). One isolate resistant to fluconazole was cross-resistant to voriconazole, and resistance to voriconazole only was observed in six other isolates. All strains were found to be susceptible to echinocandins and amphotericin B, and five were classified as resistant to 5-fluorocytosine. The sequence of the ERG11 gene encoding lanosterol 14-α demethylase (the molecular target of azoles) of 41 isolates, including all strains resistant to fluconazole and three resistant only to voriconazole, was determined, and no amino acid substitutions were found. Real-time PCR studies revealed that 13 of 15 azole-resistant strains showed upregulation of the CDR1 gene encoding the efflux pump. No upregulation of expression of the CDR2 or ERG11 gene was observed.
- Published
- 2015
- Full Text
- View/download PDF
4. Molecular epidemiology of acquired-metallo-beta-lactamase-producing bacteria in Poland.
- Author
-
Fiett J, Baraniak A, Mrówka A, Fleischer M, Drulis-Kawa Z, Naumiuk Ł, Samet A, Hryniewicz W, and Gniadkowski M
- Subjects
- Acinetobacter drug effects, Acinetobacter isolation & purification, Anti-Bacterial Agents pharmacology, Blood microbiology, DNA, Bacterial genetics, Electrophoresis, Gel, Pulsed-Field, Imipenem pharmacology, Integrons genetics, Microbial Sensitivity Tests, Molecular Epidemiology, Plasmids genetics, Poland epidemiology, Polymerase Chain Reaction, Polymorphism, Restriction Fragment Length, Pseudomonas aeruginosa classification, Pseudomonas aeruginosa drug effects, Pseudomonas aeruginosa isolation & purification, Pseudomonas putida drug effects, Pseudomonas putida isolation & purification, Retrospective Studies, Sequence Analysis, DNA, Sputum microbiology, Urine microbiology, beta-Lactamases genetics, Acinetobacter enzymology, Acinetobacter genetics, Pseudomonas aeruginosa enzymology, Pseudomonas aeruginosa genetics, Pseudomonas putida enzymology, Pseudomonas putida genetics, beta-Lactamases metabolism
- Abstract
We have analyzed 40 metallo-beta-lactamase (MBL)-producing isolates of Pseudomonas aeruginosa (n = 38), Pseudomonas putida (n = 1), and Acinetobacter genospecies 3 (n = 1) from 17 hospitals in 12 cities in Poland that were identified in 2000 to 2004. Pulsed field gel electrophoresis typing classified the P. aeruginosa isolates into eight types, with two types differentiated further into subtypes. Each of the types was specific either to a given center or to several hospitals of the same or neighboring geographic area. Almost all of the organisms produced beta-lactamase VIM-2; the only exceptions were several P. aeruginosa isolates from two centers which expressed VIM-4. The bla(VIM) genes resided exclusively within class 1 integrons, and these were located in either chromosomal or plasmid DNA. PCR-restriction fragment length polymorphism study of the variable regions of the integrons, followed by DNA sequencing, revealed the presence of eight different, mostly novel gene cassette arrays, six of which contained bla(VIM-2) and two of which contained bla(VIM-4). The occurrence of the integron variants correlated well with the geographic distribution of the MBL-producing organisms, and this suggested that their emergence in particular parts of the country had been likely due to a number of independent events. The following regional dissemination of MBL producers could be attributed to various phenomena, including their clonal spread, horizontal transmission of resistance determinants, or both. All of the data collected in this study revealed that even at this early stage of detection, the epidemiological situation concerning MBL producers in Poland has already been complex and very dynamic.
- Published
- 2006
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.